Cary Street Partners’s Fidelity Blue Chip Growth ETF FBCG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.37M Buy
54,328
+5,514
+11% +$327K 0.07% 263
2026
Q1
$2.45M Buy
48,814
+1,052
+2% +$56K 0.06% 296
2025
Q4
$2.62M Buy
47,762
+4,523
+10% +$245K 0.06% 289
2025
Q3
$2.32M Buy
43,239
+8,720
+25% +$444K 0.06% 300
2025
Q2
$1.67M Sell
34,519
-1,145
-3% -$48.8K 0.05% 336
2025
Q1
$1.43M Buy
35,664
+4,246
+14% +$192K 0.05% 331
2024
Q4
$1.45M Buy
+31,418
New +$1.42M 0.05% 327

Other funds holding FBCG

Cary Street Partners's FBCG Position: Q2 2026 in Review

Cary Street Partners increased its Fidelity Blue Chip Growth ETF (FBCG) stake by 11% in Q2 2026, buying an estimated $327K and bringing the position to 54,328 shares worth $3.37M. The position accounts for 0.07% of the portfolio, ranked #263.

Cary Street Partners first reported a position in FBCG in Q4 2024 and has held it in 7 quarters since. 144 funds tracked by Wall St. Rank hold FBCG as of Q2 2026.

  • Cary Street Partners held 54,328 shares of Fidelity Blue Chip Growth ETF worth $3.37M as of Q2 2026.
  • Cary Street Partners bought 5,514 Fidelity Blue Chip Growth ETF shares in Q2 2026, an estimated $327K.
  • Fidelity Blue Chip Growth ETF made up 0.07% of Cary Street Partners's portfolio in Q2 2026, its #263 holding.
  • Cary Street Partners first reported a position in Fidelity Blue Chip Growth ETF in Q4 2024 and has held it in 7 quarters since.
  • 144 funds tracked by Wall St. Rank held Fidelity Blue Chip Growth ETF as of Q2 2026.

Based on Cary Street Partners's 13F filing for Q2 2026, filed 17 Jul 2026.